De Quervain's Disease in the Acute Phase:a Study Aimed at Evaluating the Effectiveness of Standard Physiotherapy Treatment (HANDGUIDE), Compared to Experimental Treatment After Performing Ultrasound-guided Infiltrative Therapy.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIstituto Ortopedico Rizzoli

About this trial

The objective of the study is to compare pain reduction and disability reduction in two groups of patients diagnosed with de Quervain syndrome who will undergo ultrasound-guided infiltrative treatment with corticosteroid as per normal clinical practice:

* the control group will subsequently be subjected to a standard treatment based on the European guidelines of the HANDGUIDE group, * the experimental group will subsequently carry out a program of eccentric exercises.

Eligibility criteria

Qualifiers

Patients of both sexes with a minimum age of 18 years;

Medical diagnosis of de Quervain syndrome assessed through orthopedic clinical examination e confirmation by ultrasound;

Signing of the informed consent and participation in the study.

Disqualifiers

Patients who are not self-sufficient or not able to understand and want;

Presence of other pathologies in the hand affected by de Quervain pathology, such as intersection syndrome, neuropathies, fractures, rhizoarthrosis, arthrosis of the radio-carpal or intercarpal joint, intercarpal instability, cervical radiculopathy, rheumatic or metabolic pathologies;

Pregnant or breastfeeding women.

Trial design

Treatments tested in this trial

  • Rehabilitation
  • Standard

Treatment groups

134 Participants
are divided into 2 treatment groups

Sponsors and collaborators